U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07719543) titled 'Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease' on July 18.
Brief Summary: Immunoglobulin G4-related disease (IgG4-RD) is a chronic immune-mediated disorder characterized by inflammation, fibrosis, and involvement of multiple organs. Although glucocorticoids can effectively induce remission, many patients experience disease relapse after glucocorticoid tapering or discontinuation, and long-term glucocorticoid exposure may cause significant adverse effects. Therefore, new maintenance treatment strategies are needed to reduce relapse risk and minimize glucocorticoid-related toxicity.
This study is designed ...